Biologic and Preclinical Expertise
At BioInvent, we are dedicated to understanding an antibody's mode of action in relation to the biology of the target disease. Our preclinical work is currently focused on oncology. By utilising key in house staff and through collaborations with internationally-recognised academic groups and leading industrial partners we have built competence in the fields of cancer biology, angiogenesis, tumour immunology, innate immunity and immunology.
Over the last ten years our research and development activities have led to the creation of several state-of-the-art in vitro, in vivo, and ex vivo disease model systems. These can be used to identify the therapeutically most efficacious and potent antibodies, and to comprehensively monitor antibody safety and tolerability based on target disease biology and antibody mode of action.